Omega-3s and Blood Markers in People with Diabetes or Heart Disease
In diabetic patients, omega-3 supplementation was linked to lower triglycerides and reduced Apo AII levels compared to controls.
A growing library of the omega-3 research we're following — summarized and categorized so you can find what matters to you.
In diabetic patients, omega-3 supplementation was linked to lower triglycerides and reduced Apo AII levels compared to controls.
Omega-3 supplementation was associated with lower liver enzyme levels and reduced liver fat across pooled data from over 6,500 NAFLD patients.
A meta-analysis of seven trials found that children with ADHD who started with lower omega-3 levels showed a larger improvement from supplementation than those with normal baseline levels.
A meta-analysis of six trials found krill oil supplementation was linked to improved pain and physical function scores in people with knee osteoarthritis, with a good safety profile.
A meta-analysis of 21 trials found prenatal DHA supplementation slightly increased birth weight but showed no measurable benefit for infant neurodevelopmental outcomes.
In people with type 1 diabetes, omega-3 supplementation modestly raised HDL cholesterol and lowered triglycerides but showed no effect on blood sugar markers.